NABORS INDUSTRIES’CEO, TONY PETRELLO

Tony Petrello is famously known to be one of the highest-paid CEOs in the country. This is according to the Associated Press’s annual rankings. Tony is the current chairman and Chief Executive Officer of Nabors industries. Nabors industries is a company that offers drilling and rig services by providing rig instrumentation, optimization software, equipment manufacturing and directional drilling company. It has its headquarters in Houston, Texas and Bermuda. The company, in 2016 earned annual revenue of more than 2.2 billion dollars. In the same year, Tony earned an outstanding 15.3 million dollars when he combined his salary with stocks.

Tony was born in Newark, New Jersey. Being born in a working-class family, he was lucky enough to receive public school scholarship in Yale University. In the University he showed his passion and interest in mathematics and he graduated with a BS and MS in mathematics. Later on, Tony pursued a law degree at Harvard Law School and graduated in 1979. He later on joined a law firm, Baker and McKenzie, where he worked for about eleven years, being the managing partner of the New York offices of the law firm. A job offer was given to Tony by Nabors industries and he became the president and chief operating officer of the company. Tony became the Deputy Chairman of Narbos by 2003 and in 2011 he got his current position as the CEO.

To add to his success in his career, Tony is a well recognized good hearted philanthropist who is committed to donate to the less fortunate and charitable institutions. Tony has a daughter who has a neurological condition. This means that she cannot learn things the way a normal kid would. His daughter, Carina was born at 24 weeks and weighed only 20 ounces. Tony and his wife, Cynthia, are very dedicated to find solutions to the issues brought about by the neurological condition their daughter faces. According to Cynthia Petrello, the condition of their daughter humbled them a lot and they began to pray for divine intervention.

In an effort to give children born with this condition better lives, Tony donated 7 million dollars to The Texas Children’s Hospital in 2016. Tony’s mentor and friend, Serge Lang, who was a math professor, died last September. In his memorial, Tony gave an endowment of 150000 dollars to commemorate Serge. These are just but a few of the acts of kindness that show Tony’s generosity with his wealth.

For details: en.wikipedia.org/wiki/Nabors_Industries

Felipe Montoro Jens -Developments from Discussions Concerning Public-Private Partnerships and Concessions

The 30th of June 2017, was the first time that the relevant stakeholders met to discuss the management of projects to be done on Public-Private Partnerships (PPPs) and Concessions. According to Felipe Montoro Jens, an Infrastructure expert, subjects about public market, sanitation projects, public lighting, public clocks, Guiba Water Park as well as the construction of new head offices for the Hospital Materno Infantil Presidente Vargas dominated the discussions.

Several mayors including for the capital of Rio Grande do Sul was in attendance, and he postulated that the meeting was held to determine priorities, areas, and services that the government needed to [partner with the private sector for faster and accelerated results. According to Mayor Nelson Marcheza of Porto Alegre, PPPs is one of the mechanisms through which the Brazil can overcome its financial crisis by implemented PPPs projects in several areas of municipal administration. For this reason, the mayor had to sign the May 2 Decree 19736 that founded the Municipal Program Partnerships (PROPAR/POA) and the Program Management Board Partnerships (CGP) enabling its application.

According to Mr. Montoro, the CGP was tasked with ensuring governance and active transparency for the initiatives that will be done under the PPPs and Concessions. Owing to the financial crisis facing Brazil, participants of CGP will not be paid, and their role is a seen as purely public service initiative to improve the country’s infrastructure.

About Felipe Montero Jens

Felipe Montoro Jens is an accomplished infrastructural professional and entrepreneur with diverse experiences working as a financier, controller, and planner in both the private and public sectors of several countries like the UK, US, and Brazil. Currently, Montoro is the Director of Braskem Adr Repr. Formerly, Felipe Montoro worked at Terna S.P.A and Enron where his roles included project development and structured finance.

Other than infrastructure and property management, Felipe has worked in other sectors like water, audit, sewerage technology and petroleum. Due to his remarkable expertise and working experience, Felipe has been appointed to serve on the boards of several international businesses and establishments where his expert opinions are highly considered.

Clay Siegall goes from junior researcher to major biotech player

When Clay Siegall was still in college, a close family member became ill with cancer. Throughout the family member’s ordeal, they were given the traditional regimen of chemotherapy, a highly lethal poison that is directly administered into the bloodstream, causing widespread secondary effects. When the family member developed a severe case of anemia and nearly died as a direct result of the drugs being given to cure the cancer, Dr. Siegall decided that he would like to spend his career dedicated to the research of better ways to fight this terrible disease.

 

After receiving an MS from the University of Maryland in biology and a PhD in genetics from George Washington University, Dr. Clay Siegall was hired by the National Cancer Institute, one of the most prestigious cancer research organizations in the world. Over the course of the next four years, Dr. Siegall worked on a number of projects. One of these was a specific type of targeted cancer therapy idea that would use human antibodies as a means to deliver to lethal cytotoxin directly to the surface of tumor cells. The idea behind this delivery mechanism was that it would completely eliminate the need to systemically release large amounts of poison into the patient’s bloodstream, thereby dramatically reducing the side effects associated with traditional chemotherapeutic regimens.

 

Eventually, Dr. Siegall, who had proven himself to be a star researcher at the National Cancer Institute, was hired by Bristol-Myers Squibb, one of the largest pharmaceutical companies in the world. While there, Dr. Siegall led a team of researchers, developing some of the most innovative drug types of that ever been seen in the cancer research space. It was at this point that Dr. Siegall first coined the term antibody drug conjugates, a type of drug that uses synthetic human antibodies as the means to deliver chemotherapeutic agent directly to malignant tissues.

 

Over the next 10 years, Dr. Siegall continued working on this exciting new form of drugs. Eventually, he was able to effect the synthesis of artificial human antibodies through the use of an ingenious cloning process that he had created himself, which used live rodents to create molecular templates for synthetic human antibodies.